CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		6 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2011
Sales and contract revenues	$ 1,495,130	$ 2,092,367	$ 2,654,966	$ 3,507,585
Cost of sales and contracts	931,556	1,273,062	2,250,962	2,052,381
Gross profit	563,574	819,305	404,004	1,455,204
Selling, general and administration expenses	593,552	719,588	1,131,548	1,464,958
Impairment of note receivable	1,516,338		1,516,338
Research and development costs	184,876	127,398	358,972	226,860
Total operating expenses	2,294,766	846,986	3,006,858	1,691,818
Operating loss	(1,731,192)	(27,681)	(2,602,854)	(236,614)
Other income
Interest income	34,448	29,585	51,767	67,877
Other income (expense)	(23,941)	4,871	45,030	11,351
Total other income	10,507	34,456	96,797	79,228
Income (loss) from operations before income taxes	(1,720,685)	6,775	(2,506,057)	(157,386)
Income tax expense (benefit)	513,430	2,304	513,430	(53,511)
Net income (loss) before discontinued operations	(2,234,115)	4,471	(3,019,487)	(103,875)
Loss from discontinued operations				(18,044)
Income tax benefit from discontinued operations				6,135
Net loss from discontinued operations				(11,909)
Net income (loss)	$ (2,234,115)	$ 4,471	$ (3,019,487)	$ (115,784)
Basic loss per common share
Continuing operations	$ (0.96)		$ (1.30)	$ (0.04)
Discontinued operations				$ (0.01)
Net loss	$ (0.96)		$ (1.30)	$ (0.05)
Diluted loss per common share
Continuing operations	$ (0.96)		$ (1.30)	$ (0.04)
Discontinued operations				$ (0.01)
Net loss	$ (0.96)		$ (1.30)	$ (0.05)
Basic weighted average of common shares outstanding	2,322,578	2,313,569	2,320,319	2,312,346
Diluted weighted average of common shares outstanding	2,322,578	2,313,569	2,320,319	2,312,346